Fact CheckerSign in

NCT06868537Recruiting

A Trial of the Launching! to Adulthood Program

A Randomized Controlled Trial of the Launching! to Adulthood Program

Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine whether the Launching intervention leads to improvements in executive functioning, co-occurring mental health symptoms, and quality of life, as measured by caregiver and self-report assessments, to assess the maintenance of treatment gains 12 weeks post-treatment and to replicate the findings of the Launching pilot study in an independent sample of young adults with ASD.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
5 Mar 2025
Start date
15 Jul 2025
Primary completion date
1 Aug 2027
Lead sponsor
The University of Texas Health Science Center, Houston
Diseases
Autism
NCT number
NCT06868537

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 15 Jul 2025 to the primary completion date, 1 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • concurrent enrollment in another clinical trial for autism spectrum disorder

Other illness

  • history of a psychotic disorder or current psychotic symptoms
  • current alcohol or other substance use disorder rated severe

Other

  • suicidal ideation with intent or plan
  • expression of unwillingness to complete study procedures

Who the study is looking for

  • confirmed case of ASD from a licensed mental health or medical professional
  • score of \>14 on the Social Communication Questionnaire-Lifetime (SCQ-L) completed with the mother or father
  • meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ASD symptom checklist
  • willing and motivated to participate in the treatment
  • a parent willing to participate
  • verbal intelligence quotient (IQ) score \>70 as assessed by the Kaufman Brief Intelligence Test 2nd edition revised (KBIT-2-R)

Age in the registry: 18 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The University of Texas Health Science Center at Houston
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.